Demand for Bioabsorbable osteosynthesis devices is being positively influenced by growing body of research about its efficacy. According to a research paper published in MDPI, its efficacy in reducing the need for a secondary surgery continues to boost its case among researchers and healthcare community.
Bioabsorbable stents have recently been developed by Fluid Biotech Inc. as a novel way to treat brain aneurysms. The smart stent systems reduce several adverse incidents that are associated with stents. Smart stent remains the favourite research subjects for researchers as their potential seems to provide real time monitoring to mitigate the clinical problems associated with current cardiovascular stents.
Considering the nature of the product, manufacturers are relying on R&D efforts and quicker regulatory approval.
Colson Medical, LLC announced the merger of its two companies, Acumed and OsteoMed in October 2020. The two leaders are known for providing innovative, practical products for surgeries. Now, the combined business is focussing on prevalent surgeries, i.e. hand/upper extremity, foot/ankle, trauma including chest wall injury, craniomaxillofacial and neurosurgery, tendon/ligament repair and biologics. The merger is expected to give their patients healthier and improved experience.
Another leading player, Smith + Nephew in September 2020 announced their acquisition of Extremity Orthopaedics business of Integra Life sciences Holdings Corporation. The acquisition seems to reinforce the business by introducing focussed sales channel, portfolio for shoulder replacement and upper/lower extremities. The company is likely to invest in higher growth segments.
In 2019, Microport Orthopedics, a medical device manufacturing company launched the Evolution NitrX, Medical-Pivot Knee featuring a titanium nitride coating to reduce the release of cobalt, chromium, molybdenum, and nickel ions in standard implant. The development has helped patients in recovery having less pain. The patients treated with the help of NitrX are in better condition after surgery as compared to the previous patients.
Bioabsorbable osteosynthesis devices have prevailed as one of the key areas of interest among multidisciplinary researchers over the past couple of years. Bioabsorbable materials have gained significant attention of maxillofacial surgeons recently, in tandem with increasing research and newer advancements in the bioabsorbable osteosynthesis implants.
Requirement for stable fixation for optimal modelling in maxillofacial osteosynthesis surgeries cannot be completely met by the traditionally used titanium plates, as they are limited by interference with imaging, mutagenic effects, and visibility. Adoption of bioabsorbable osteosynthesis devices has been deemed to hold immense potential in addressing or offsetting these limitations. However, use of bioabsorbable osteosynthesis devices continues to witness the confines of lower mechanical strength & stability, uncertainties in materials’ availability, convolute procedures and slow biodegradation.
Major advancements in the bio absorbable osteosynthesis devices are being made in recent years by using bioactive osteoconductive materials along with an accelerator compound. Prominent players are increasingly focusing on strengthening their hold in the supply chain to expand the market penetration of their existing bioabsorbable osteosynthesis devices, while taking efforts on innovative material advancements and newer product developments.
Leading players in the bioabsorbable osteosynthesis devices market have been emphasizing on the need for developing complete body absorbable solutions. This has led to the discovery of a new process called orientrusion, which enables enhancing the strength of polylactide to be completely biocompatible and absorbable. Bioabsorbable osteosynthesis devices manufactured by using orientruded polylactide have witnessed successful application in fixation of the medial malleolar fractures.
Osteosynthesis is a surgical practice that joins the ends of a fractured bone by mechanical devices such as plates, rods, wires, pins and screws. Traditional practices included all sort of material choices, but metal implants, stainless-steel and titanium material choice are the most used metal implants that are available due to their positive characteristics. Biocompatibility is a major factor that is required to build an implant.
Technological advancements have helped in providing a more resourceful choice of material for developing implants. One such material is the bioabsorbable material through which devices are manufactured in response to its high biocompatibility and body-absorbable quality. The need for the totally body absorbable internal bone fixation devices has been there since the arrival of complications related to the use of metal implants such as infections, weakness or fatigue, diarrhea and headaches with many other major problems.
Therefore, the introduction of bioabsorbable osteosynthesis devices, which would eliminate the procedure of removing these devices from the body (if required) after the bone is healed, will help in creating an impact and these devices are not that stiff as the currently used metallic implants and therefore would limit the chances of further complications. A process is required to develop and synthesize high molecular weight, low monomer content polylactide.
A high-quality polymer used involves chemical and mechanical tests with simulated in vitro tests. Biocompatibility of the polymer used is also practiced in rabbit and canine models for further development.
The global bioabsorbable osteosynthesis devices market is apprehended to see impressive growth in the near future due to new product launches, an encouraging sign can be observed in the sector with changing consumer trends. The expansion in products manufactured with bioabsorbable material is driven by year on year rises in the susceptible complications observed in the use of metal implants.
Top players are marking their presence in many developing economies due to the liberal policies regulated within the healthcare industry in such countries, increasing consumer inclination towards maintaining an aesthetic and approachable appearance. Priority is given to eliminate the adverse effects such as migraine, growth disturbance, radio-opacity and more and provide a safe environment for the body.
Bioabsorbable polymers are manufactured with a lot of judgment calls in order to provide a safe material to be in use. As the applications of bioabsorbable osteosynthesis devices in orthopaedic surgery have mainly been used to eliminate implant removal procedures. Choices of materials are there with companies investing on such research and but with majority of devices being manufactured using non-bioabsorbable material due to the traditional methods or major dependency on such principles which could hamper the growth in the near future.
By Product Type
By End Users
Though all the products have their importance in certain procedures but screws remain a dominant due to its effectiveness and usage over other product types. PLLA is a preferred choice by manufacturers with less effects and more research is associated with it. Hospitals remain to be the most lucrative market due to its active osteosynthesis procedures.
On the basis of regional presence, the global market is segmented into six key regions viz. North America, Latin America, Europe, Asia-Pacific Excluding China, China and Middle East & Africa. North America holds the dominant share and is expected to continue the growth over the forecast period due to major companies’ market presence. Asia Pacific is expected to be an attractive region in terms of investment provided to the research wing in developing sector.
Population density is expected to escalate in the Asia Pacific (exc. China) region allowing opportunity for bioabsorbable osteosynthesis devices to establish and produce goods within the region. Europe is expected to grow at a higher rate due to rise in population, changing lifestyle and rise in awareness among consumers and suppliers. China is expected to have a fragmented growth with more number of regional players and low adoption of bioabsorbable material.
Economic growth is supporting the health care infrastructure in developing countries allowing more number of players to contribute with ease and efficiency. Examples of some of the key players are Arthrex, CONMED Corporation, Acumed, Ziacom Medical, ETGAR medical implant system, Jeil Medical Corporation, Medical Instinct Deutschland GmbH and more. Acquisition, mergers, strategic collaborations, and technology play vital roles in the growth of the market.
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.